Immunome logo

Immunome Share Price (NASDAQ: IMNM)

$9.51

-0.39

(-3.94%)

Last updated on

Check the interactive Immunome Stock chart to analyse performance

Immunome stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$9.42
    Today's High:$9.86

    Day's Volatility :4.51%

  • 52 Weeks Low:$5.15
    52 Weeks High:$16.73

    52 Weeks Volatility :69.22%

Immunome Stock Returns

PeriodImmunome IncIndex (Russel 2000)
3 Months
4.8%
0.0%
6 Months
6.21%
0.0%
1 Year
-32.37%
0.0%
3 Years
66.58%
-4.7%

Immunome Inc Key Stats

Check Immunome key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$9.9
Open
$9.86
Today's High
$9.86
Today's Low
$9.415
Market Capitalization
$861.7M
Today's Volume
$684.1K
52 Week High
$16.73
52 Week Low
$5.1501
Revenue TTM
$12.6M
EBITDA
$-188.4M
Earnings Per Share (EPS)
$-3.05
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-81.2%

Stock Returns calculator for Immunome Stock including INR - Dollar returns

The Immunome stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Immunome investment value today

Current value as on today

₹73,019

Returns

₹26,981

(-26.98%)

Returns from Immunome Stock

₹32,265 (-32.26%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Immunome Stock

-86%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Immunome Stock from India on INDmoney has decreased by -86% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Immunome Inc

  • Name

    Holdings %

  • T. Rowe Price Investment Management,Inc.

    9.51%

  • BlackRock Inc

    6.51%

  • Redmile Group, LLC

    5.60%

  • Enavate Sciences GP, LLC

    5.48%

  • Point72 Asset Management, L.P.

    5.39%

  • Vanguard Group Inc

    5.20%

Analyst Recommendation on Immunome Stock

Rating
Trend

Buy

    90%Buy

    9%Hold

    0%Sell

Based on 11 Wall street analysts offering stock ratings for Immunome(by analysts ranked 0 to 5 stars)

Immunome Share Price Target

What analysts predicted

Upside of 147.69%

Target:

$23.56

Current:

$9.51

Immunome share price target is $23.56, a slight Upside of 147.69% compared to current price of $9.51 as per analysts' prediction.

Immunome Stock Insights

  • Price Movement

    In the last 7 days, IMNM stock has moved down by -7.8%
  • IMNM vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 69.9% return, outperforming this stock by 107.4%
  • IMNM vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 45.7%
  • Price to Sales

    ForIMNM every $1 of sales, investors are willing to pay $54.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.5 for every $1 of sales.

Immunome Technicals Summary

Sell

Neutral

Buy

Immunome is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Immunome Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Immunome Inc logo
-10.34%
6.21%
-32.37%
66.58%
-29.41%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Immunome Inc

Immunome, Inc., a clinical-stage biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises Varegacestat, a gamma secretase inhibitor that is in Phase 3 clinical trial for the treatment of desmoid tumors; and IM-1021, a receptor tyrosine kinase-like orphan receptor 1 antibody-drug conjugate (ADC), which is in Phase 1 clinical trial. Its preclinical assets include IM-3050, a fibroblast activation protein targeted radioligand therapy; and solid tumor ADC drug candidates, including IM-1617, IM-1340, and IM-1335. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.
Organization
Immunome
Employees
155
CEO
Dr. Clay B. Siegall Ph.D.
Industry
Health Technology

Key Management of Immunome Inc

NameTitle
Dr. Clay B. Siegall Ph.D.
Chairman, President & CEO
Ms. Sandra G. Stoneman Esq., J.D.
Chief Legal Officer, General Counsel & Corporate Secretary
Mr. Kinney Horn
Chief Business Officer
Mr. Max Rosett
Chief Financial Officer
Dr. Philip Tsai
Chief Technical Officer
Dr. Jack Higgins Ph.D.
Chief Scientific Officer
Dr. Robert J. Lechleider M.D.
Chief Medical Officer
Mr. Roee Shahar
Executive Vice President of Commercial

Important FAQs about investing in IMNM Stock from India :

What is Immunome share price today?

Immunome share price today is $9.51 as on at the close of the market. Immunome share today touched a day high of $9.86 and a low of $9.42.

What is the 52 week high and 52 week low for Immunome share?

Immunome share touched a 52 week high of $16.73 and a 52 week low of $5.15. Immunome stock price today i.e. is closed at $9.51, lower by 43.16% versus the 52 week high.

How to invest in Immunome Stock (IMNM) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immunome on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunome Shares that will get you 0.1577 shares as per Immunome share price of $9.51 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Immunome Stock (IMNM) from India?

Indian investors can start investing in Immunome (IMNM) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Immunome stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Immunome share’s latest price of $9.51 as on August 30, 2025 at 1:29 am IST, you will get 1.0515 shares of Immunome. Learn more about fractional shares .

What are the returns that Immunome has given to Indian investors in the last 5 years?

Immunome stock has given -29.41% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?